Neuropeptide CGRP Limits Group 2 Innate Lymphoid Cell Responses and Constrains Type 2 Inflammation.
Immunity. 2019 Oct 15;51(4):682-695.e6. doi: 10.1016/j.immuni.2019.06.009. Epub 2019 Jul 25.
Immunity. 2019.
PMID: 31353223
Free PMC article.